Article
Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.
Thrombosis and haemostasis - 1 Mar 2007
Vokó Zoltán, Bereczky Zsuzsanna, Katona Eva, Adány Róza, Muszbek László
Abstract excerpt
Several studies suggested that Val34Leu variant of factor XIII (FXIII) might have a protective effect against coronary artery disease (CAD), but studies not supporting these findings have also been published. The authors performed a meta-analysis of 16 studies on 5,346 cases and 7,053 controls that investigated the association between Val34Leu polymorphism and CAD defined as history of myocardial infarction or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
